Latest filing published 24 Feb 2021 for Blueprint Medicines Corp, €232k.
Filing timeline
BuySaleInsider track record
Marion Dorsch: trading record in brief
Marion Dorsch is a declared insider of Blueprint Medicines Corp, with filings sourced from SEC (Form 4). We count 39 filings; the first trade dates from 21 November 2017 and the latest from 22 February 2021.
Every open-market trade on record is a sale: 26 sales worth €5.0M. Outside the open market, there are 1 share grant and 12 option exercises. Since January 2021: no purchases and 1 sale on the market.
On 24 February 2021 came the latest disclosure, an open-market sale for €625k in Blueprint Medicines Corp. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Marion Dorsch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,578 shares@ US$37.113.2% of flowCommon StockSEC:0001179110-21-002211:0
- 7,578 shares@ US$100.008.6% of flowCommon StockSEC:0001179110-21-002211:1
- 4,600 shares@ US$37.116.6% of flowCommon StockSEC:0001179110-20-011988:0
- 4,600 shares@ US$119.0021.2% of flowCommon StockSEC:0001179110-20-011988:1
- 4,600 shares@ US$37.116.7% of flowCommon StockSEC:0001179110-20-010351:0
- 4,600 shares@ US$99.0017.8% of flowCommon StockSEC:0001179110-20-010351:1
- 4,600 shares@ US$37.116.7% of flowCommon StockSEC:0001179110-20-009960:0
- 4,600 shares@ US$89.0016.1% of flowCommon StockSEC:0001179110-20-009960:1
- 4,600 shares@ US$37.115.7% of flowCommon StockSEC:0001179110-20-007715:0
- 4,600 shares@ US$79.0012.2% of flowCommon StockSEC:0001179110-20-007715:1
- 199 shares@ US$55.140.4% of flowCommon StockSEC:0001179110-20-004115:0
- 241 shares@ US$53.430.5% of flowCommon StockSEC:0001179110-20-004115:1
- 774 shares@ US$51.521.4% of flowCommon StockSEC:0001179110-20-004115:2
- 536 shares@ US$51.990.9% of flowCommon StockSEC:0001179110-20-003475:0
- 10,000 shares0Common StockSEC:0001179110-20-002955:0
- 4,600 shares@ US$37.114.4% of flowCommon StockSEC:0001179110-19-013128:0
- 4,600 shares@ US$79.009.4% of flowCommon StockSEC:0001179110-19-013128:1
- 4,600 shares@ US$37.114.1% of flowCommon StockSEC:0001179110-19-007897:0
- 4,600 shares@ US$99.0011.0% of flowCommon StockSEC:0001179110-19-007897:1
- 107 shares@ US$82.560.2% of flowCommon StockSEC:0001179110-19-003446:5
- 2,300 shares@ US$37.112.0% of flowCommon StockSEC:0001179110-19-003446:0
- 295 shares@ US$87.730.6% of flowCommon StockSEC:0001179110-19-003446:1
- 498 shares@ US$85.641.0% of flowCommon StockSEC:0001179110-19-003446:2
- 600 shares@ US$84.721.2% of flowCommon StockSEC:0001179110-19-003446:3
- 800 shares@ US$83.161.6% of flowCommon StockSEC:0001179110-19-003446:4
25 of 38 declarations
